Bay Street News, February 27th, 2024

VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — FIREWEED METALS CORP. (“Fireweed” or the “Company”) (TSXV: FWZ; OTCQB: FWEDF; […]

MIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd., “Norwegian Cruise Line […]

WEST CHESTER, Pa., Feb. 27, 2024 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology […]

NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) — Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative […]

TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments) announced that effective today it is expanding its […]

TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), […]

TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) — EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold Global” […]

Generated $397 million in full year 2023 revenues, including $275 million for SYFOVRE®(pegcetacoplan injection) and $91 million for EMPAVELI®(pegcetacoplan) Strong […]

2023 net revenues increased 4.5% to $1.05 billion, compared to 2022 2023 net income of $51 million or $0.18 per […]

THE WOODLANDS, Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) — ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX) announced today the […]